Evaluation of Fibrin Sealant 2 in Retroperitoneal or Intra-Abdominal Surgery

Inclusion Criteria: Male and Female subjects requiring non-emergent retroperitoneal or intra-abdominal surgical procedures Presence of an appropriate soft-tissue target bleeding site (challenging bleeding site for which topical hemostatic adjuncts might typically be used) as identified intra-operatively by the surgeon Subjects must be willing to participate in the study and provide written informed consent Exclusion Criteria: Subjects undergoing emergency surgery Parenchymal or anastomotic bleeding sites will not be considered for randomization Subjects with any intra-operative findings identified by the surgeon that may preclude conduct of the study procedure Subjects with known intolerance to blood products or to one for the components of the study product Subjects unwilling to receive blood products Subjects with known autoimmune immunodeficiency diseases (including known HIV Subjects who are known, current alcohol and/or drug abusers Subjects who have participated in another investigational drug or device research study within 30 days of enrollment Female subjects who are pregnant or nursing